Safety differences tend to be molecule and indication-specific rather than route-driven, and regulators evaluate benefitrisk case by case, Campbell said
Synthetic biology-based approaches, such as SYNB1891, a live microbial vector delivering STING agonists, have been evaluated for intratumoral immune activation in metastatic tumors (NCT04167137)
(Note April 14 th , 2025 Pfizer announced discontinuation of development of danuglipron because of drug-induced liver injury.) The full results of the ACHIEVE-1 trial will be presented at the forthcoming American Diabetic Association meeting in June 2025 and will be published in a peer-reviewed journal
However, these drugs come with a significant out-of-pocket cost
C.ZhengX
If your prescription references "units," contact your healthcare provider immediately for clarification before administering any dose